--- title: "National Research Corporation (NRC.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/NRC.US.md" symbol: "NRC.US" name: "National Research Corporation" industry: "Health Care Services" --- # National Research Corporation (NRC.US) | Item | Detail | |------|--------| | Industry | Health Care Services | | Location | US Market | | Website | [www.nrchealth.com](https://www.nrchealth.com) | ## Company Profile National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical,... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-20T04:30:12.000Z **Overall: C (0.48)** **Industry**: Health Care Services | Metric | Value | |--------|-------| | Industry Ranking | 44 / 86 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -3.96% | | | Net Profit YoY | -53.19% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 20.15 | | | Dividend Ratio | 4.18% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 281.83M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 137.39M | | **Multi Score**: C #### Profit Score: A | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 51.24% | A | | Profit Margin | 8.44% | B | | Gross Margin | 61.88% | A | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -3.96% | D | | Net Profit YoY | -53.19% | D | | Total Assets YoY | 1.76% | C | | Net Assets YoY | -55.28% | E | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 1184.40% | B | | OCF YoY | -3.96% | D | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 1.03 | A | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 89.63% | E | ```chart-data:radar { "title": "Longbridge Financial Score - National Research Corporation", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "A", "indicators": [ { "name": "ROE", "value": "51.24%", "rating": "A" }, { "name": "Profit Margin", "value": "8.44%", "rating": "B" }, { "name": "Gross Margin", "value": "61.88%", "rating": "A" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "-3.96%", "rating": "D" }, { "name": "Net Profit YoY", "value": "-53.19%", "rating": "D" }, { "name": "Total Assets YoY", "value": "1.76%", "rating": "C" }, { "name": "Net Assets YoY", "value": "-55.28%", "rating": "E" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "1184.40%", "rating": "B" }, { "name": "OCF YoY", "value": "-3.96%", "rating": "D" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "1.03", "rating": "A" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "89.63%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Cigna (US.CI) | B | B | A | D | B | B | | 02 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B | | 03 | Labcorp (US.LH) | B | C | B | C | B | B | | 04 | Quest Diagnostics (US.DGX) | B | B | B | C | B | B | | 05 | BrightSpring Health Services (US.BTSG) | C | A | A | D | A | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 24.30 | 14/79 | 24.06 | 16.16 | 13.21 | | PB | 20.15 | 53/79 | 25.64 | 13.54 | 10.67 | | PS (TTM) | 2.05 | 48/79 | 2.72 | 2.42 | 2.07 | | Dividend Yield | 4.18% | 2/79 | 3.76% | 3.24% | 2.86% | ## References - [Company Overview](https://longbridge.com/en/quote/NRC.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/NRC.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/NRC.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.